Incidence and severity of medication-related osteonecrosis of the jaw in patients with osteoporosis using data from a Korean nationwide sample cohort in 2002 to 2019: a retrospective study

Incidence and severity of medication-related osteonecrosis of the jaw in patients with osteoporosis using data from a Korean nationwide sample cohort in 2002 to 2019: a retrospective study

Background Medication-related osteonecrosis of the jaw (MRONJ) is a significant concern, particularly among patients taking bisphosphonates (BPs), denosumab, and selective estrogen receptor modulators (SERMs) for osteoporosis. Despite the known risks, large-scale cohort studies examining the inciden...

Full description

Bibliographic Details
Main Authors:	Su-Youn Ko, Tae-Yoon Hwang, Kiwook Baek, Chulyong Park
Format:	Article
Language:	English
Published:	Yeungnam University College of Medicine, Yeungnam University Institute Medical Science 2024-01-01
Series:	Journal of Yeungnam Medical Science
Subjects:	bisphosphonate osteonecrosis of jaw osteoporosis selective estrogen receptor modulators
Online Access:	http://www.e-jyms.org/upload/pdf/jyms-2023-01116.pdf

Similar Items

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

A Multi-Center Observation Study on Medication-Related Osteonecrosis of the Jaw (MRONJ) in Patients with Osteoporosis, and Other Non-Malignant Bone Diseases, in Northwestern Italy over 16 Years
by: Dora Karimi, et al.
Published: (2024-09-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

The Use of Imaging Methods in the Diagnosis of Bisphosphonate-related Osteonecrosis of the Jaw
by: L. Hauer, et al.
Published: (2012-03-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Awareness, perceptions and attitudes toward medication-related osteonecrosis of the jaw among physicians who treat osteoporosis
by: Suad Aljohani
Published: (2023-09-01)

Knowledge Level of Physicians Prescribing Bisphosphonates: Prevention and Treatment of Medication-Related Osteonecrosis of the Jaw
by: Tahereh Padeganeh, et al.
Published: (2024-10-01)

Medication-Related Osteonecrosis of the Jaw in Dental Practice: A Retrospective Analysis of Data from the Milan Cohort
by: Cristina Mirelli, et al.
Published: (2022-05-01)

OSTEONECROSIS OF THE JAW ASSOCIATED WITH SHORT-COURSE AND LOW-DOSE CORTICOSTEROID THERAPY
by: Lavinia Cristina Pădurariu, et al.
Published: (2023-12-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Bisphosphonate-associated jaw osteonecrosis in the treatment of rheumatoid arthritis
by: Gabriela Dias Rosso dos Santos, et al.
Published: (2024-11-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

Osteonecrosis of the Jaw and Bilateral Atypical Femoral Fracture Both Occurring During Treatment for Osteoporosis: A Case Report
by: Edelissa Payumo, et al.
Published: (2018-09-01)

Medication‐related osteonecrosis of the jaw: Case series and literature review
by: Denis Kimathi, et al.
Published: (2024-04-01)

Therapeutic Effect of Benidipine on Medication-Related Osteonecrosis of the Jaw
by: Ken Matsunaka, et al.
Published: (2022-08-01)

Osteonecrosis of the Jaws in Treatment with Bisphosphonates
by: M. Machálka, et al.
Published: (2006-12-01)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

Chinese expert consensus on the diagnosis and clinical management of medication-related osteonecrosis of the jaw
by: Han-Jin Ruan, et al.
Published: (2024-12-01)

History and Etiology of Jawbones Osteonecrosis
by: L. Hauer
Published: (2009-12-01)

A Novel Disorder of Osteoporosis, Osteonecrosis, and Metaphyseal Fracture
by: Hans‐Georg Zmierczak, et al.
Published: (2020-06-01)

EPIDEMIOLOGICAL INVESTIGATION OF THE CLINICAL MANIFESTATION OF BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAWS IN 112 ONCOLOGY PATIENTS
by: Meri Hristamyan, et al.
Published: (2025-02-01)

Local re-activation of osteoclast differentiation as a novel therapeutic strategy for osteonecrosis of the jaw
by: Tommaso Zanocco-Marani, et al.
Published: (2024-07-01)

Histopathological assessment of the preventive effect of leukocyte-platelet-rich fibrin on bisphosphonate-related osteonecrosis of the jaw following dental extraction: An animal study
by: Milad Etemadi Sh, et al.
Published: (2023-07-01)

Autologous Platelet-Rich Fibrin (PRF) as an Adjunct in the Management of Osteoradionecrosis and Medication-Related Osteonecrosis of Jaws. Case Series in A Single Centre
by: Benjie Law, et al.
Published: (2021-04-01)

Comparison of the Effectiveness of Conservative and Surgical Treatment of Medication-Related Osteonecrosis of the Jaw: a Systematic Review
by: Rial Seluki, et al.
Published: (2023-12-01)

Case Report: single low-dose of denosumab as a trigger of MRONJ development in a patient with osteoporosis after bisphosphonate therapy
by: Dávid Száraz, et al.
Published: (2024-12-01)

Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?
by: Gianluca Tenore, et al.
Published: (2020-04-01)

Long-term consequences of osteoporosis therapy with bisphosphonates
by: Bárbara Gehrke, et al.
Published: (2023-11-01)

Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ)
by: Sven Otto, et al.
Published: (2021-05-01)

Effectiveness of Leukocyte- and Platelet-rich Fibrin in the Management of Medication-related Osteonecrosis of the Jaws – A Systematic Review
by: Rahul Mohandas, et al.
Published: (2024-06-01)

Education and Communication on the Topic of Osteonecrosis of the Jaw When Taking Bone‐Stabilizing Drugs
by: Franz Gustav Saur, et al.
Published: (2024-12-01)

Prevention Of Drug-Induced Osteonecrosis Of The Jaw In Cancer Patients
by: E. M. Spevak, et al.
Published: (2022-07-01)

Maxillary osteonecrosis of the jaw. A multidisciplinary approach, communication strategies, and technological tools for prophylaxis
by: Mihai Vlad Golu, et al.
Published: (2024-03-01)

The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024-03-01)

Medication-related osteonecrosis of the jaw in a patient with rheumatoid arthritis with suspected involvement of methotrexate and tocilizumab
by: Keisuke Seki, et al.
Published: (2024-10-01)

Comparing the effects of low-level laser therapy and gaseous ozone as a preventive measure on medication-related osteonecrosis of the jaws following tooth extraction: a rat model
by: Öznur Özalp, et al.
Published: (2024-07-01)

Medication-Related Osteonecrosis: Why the Jawbone?
by: Sydney Kuehn, et al.
Published: (2023-04-01)

MicroRNA-21-5p profile in the alveolar bone following tooth extraction in medication-related osteonecrosis of the jaw rat model
by: Manta Morakotsriwan, et al.
Published: (2024-12-01)

Electron microscopic analysis of necrotic bone and failed implant surface in a patient with medication-related osteonecrosis of the jaw
by: Ji Young Ha, et al.
Published: (2023-10-01)

Spontaneous Osteogenic Potential of Periosteum after Segmental Mandibulectomy in Patients with Medication-Related Osteonecrosis of the Jaw (MRONJ): A Retrospective Study of 14 Cases
by: Youngmin Kwon, et al.
Published: (2023-04-01)